Literature DB >> 18093579

The detached locus encodes Drosophila Dystrophin, which acts with other components of the Dystrophin Associated Protein Complex to influence intercellular signalling in developing wing veins.

Christina P Christoforou1, Claire E Greer, Benjamin R Challoner, Dimitris Charizanos, Robert P Ray.   

Abstract

Dystrophin and Dystroglycan are the two central components of the multimeric Dystrophin Associated Protein Complex, or DAPC, that is thought to provide a mechanical link between the extracellular matrix and the actin cytoskeleton, disruption of which leads to muscular dystrophy in humans. We present the characterization of the Drosophila 'crossveinless' mutation detached (det), and show that the gene encodes the fly ortholog of Dystrophin. Our genetic analysis shows that, in flies, Dystrophin is a non-essential gene, and the sole overt morphological defect associated with null mutations in the locus is the variable loss of the posterior crossvein that has been described for alleles of det. Null mutations in Drosophila Dystroglycan (Dg) are similarly viable and exhibit this crossvein defect, indicating that both of the central DAPC components have been co-opted for this atypical function of the complex. In the developing wing, the Drosophila DAPC affects the intercellular signalling pathways involved in vein specification. In det and Dg mutant wings, the early BMP signalling that initiates crossvein specification is not maintained, particularly in the pro-vein territories adjacent to the longitudinal veins, and this results in the production of a crossvein fragment in the intervein between the two longitudinal veins. Genetic interaction studies suggest that the DAPC may exert this effect indirectly by down-regulating Notch signalling in pro-vein territories, leading to enhanced BMP signalling in the intervein by diffusion of BMP ligands from the longitudinal veins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18093579     DOI: 10.1016/j.ydbio.2007.09.044

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  33 in total

Review 1.  Extracellular matrix and its receptors in Drosophila neural development.

Authors:  Kendal Broadie; Stefan Baumgartner; Andreas Prokop
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

Review 2.  Duchenne muscular dystrophy animal models for high-throughput drug discovery and precision medicine.

Authors:  Nalinda B Wasala; Shi-Jie Chen; Dongsheng Duan
Journal:  Expert Opin Drug Discov       Date:  2020-01-30       Impact factor: 6.098

Review 3.  Protein O-mannosylation in animal development and physiology: from human disorders to Drosophila phenotypes.

Authors:  Naosuke Nakamura; Dmitry Lyalin; Vladislav M Panin
Journal:  Semin Cell Dev Biol       Date:  2010-04-01       Impact factor: 7.727

4.  Fruit flies in biomedical research.

Authors:  Michael F Wangler; Shinya Yamamoto; Hugo J Bellen
Journal:  Genetics       Date:  2015-01-26       Impact factor: 4.562

5.  Drosophila Dystroglycan is a target of O-mannosyltransferase activity of two protein O-mannosyltransferases, Rotated Abdomen and Twisted.

Authors:  Naosuke Nakamura; Stephanie H Stalnaker; Dmitry Lyalin; Olga Lavrova; Lance Wells; Vladsilav M Panin
Journal:  Glycobiology       Date:  2009-12-07       Impact factor: 4.313

6.  Dystroglycan and mitochondrial ribosomal protein L34 regulate differentiation in the Drosophila eye.

Authors:  Yougen Zhan; Nadia Y Melian; Mario Pantoja; Nicola Haines; Hannele Ruohola-Baker; Charles W Bourque; Yong Rao; Salvatore Carbonetto
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

7.  Genetic elevation of sphingosine 1-phosphate suppresses dystrophic muscle phenotypes in Drosophila.

Authors:  Mario Pantoja; Karin A Fischer; Nicholas Ieronimakis; Morayma Reyes; Hannele Ruohola-Baker
Journal:  Development       Date:  2012-11-15       Impact factor: 6.868

8.  Mechanical and non-mechanical functions of Dystrophin can prevent cardiac abnormalities in Drosophila.

Authors:  Ouarda Taghli-Lamallem; Krzysztof Jagla; Jeffrey S Chamberlain; Rolf Bodmer
Journal:  Exp Gerontol       Date:  2013-11-12       Impact factor: 4.032

9.  Dystroglycan and perlecan provide a basal cue required for epithelial polarity during energetic stress.

Authors:  Vincent Mirouse; Christina P Christoforou; Cornelia Fritsch; Daniel St Johnston; Robert P Ray
Journal:  Dev Cell       Date:  2009-01       Impact factor: 12.270

Review 10.  The roles of the dystrophin-associated glycoprotein complex at the synapse.

Authors:  Gonneke S K Pilgram; Saranyapin Potikanond; Richard A Baines; Lee G Fradkin; Jasprina N Noordermeer
Journal:  Mol Neurobiol       Date:  2009-11-09       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.